Rajnish Wellness Fair Value

Average Fair Value
₹15.57
Current Market Price: ₹0.4
+3791.67% Price Difference

Rajnish Wellness (RAJNISH) average fair value is ₹15.57 across 3 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, vs a current market price of ₹0.4 (+3791.67%), fair value range ₹7.01–₹29.59. Read RAJNISH ex-dividend dates for the complete payout history and dividend yield track record.

Fair Value Analysis Export

RAJNISH Fair Value vs Current Price — Valuation Summary

RAJNISH average fair value, fair value range, price gap and valuation status across 3 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation. For live price and a broader fundamental view, visit Rajnish Wellness screener.

Average Fair Value
₹15.57
Current Market Price
₹0.4
Price Difference
₹15.17
Percentage Difference
+3791.67%
Fair Value Range
₹7.01 - ₹29.59
Methods Used
3
Analysis based on 3 valuation methods: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation

P/B Based Valuation

Book Value/Share ₹10.1
Sector Avg P/B 4.36
Historical Avg P/B N/A
Average Fair Value
₹29.59

Price-to-Sales Valuation

Revenue/Share ₹1.75
Sector Avg P/S 4.0
Fair Value
₹7.01

Asset-Based Valuation

Book Value/Share ₹10.1
Liquidation Value/Share ₹7.48
Fair Value
₹10.1

RAJNISH Fair Value Analysis — Data Sources & Coverage

Rajnish Wellness financial data sources, valuation methods applied and sector benchmarks used. Browse Rajnish Wellness financial data for revenue, profit, balance sheet and cash flow data.

Methods Used
3
Sector
Healthcare

Available Data Sources: Financial statements, balance sheet data , sector comparisons.

RAJNISH vs Healthcare Sector Peers — P/E, P/B & Market Cap

Rajnish Wellness P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.

Company Symbol P/E Ratio P/B Ratio Market Cap (₹ Cr)
Aurobindo Pharma AUROPHARMA 25.88 2.53 ₹96,652
Emcure Pharmaceuticals EMCURE 36.8 7.52 ₹37,799
Sat Kartar Life SATKARTAR 13.37 3.34 ₹226
Syngene International SYNGENE 69.95 3.2 ₹15,307
Divis Laboratories DIVISLAB 85.36 14.9 ₹247,470

Important Disclaimer

This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.

This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.

Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.